Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FeNO Profile of FF/VI in Adult Asthma
NCT02712047Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2016
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone in asthma, sponsored by GSK. Started Apr 2016; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02712047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712047.